CEO News

Other steps include: ensuring that every Lilly product on the market and every drug entering large-scale development will have a Product Safety Physician responsibile for safety issues throughout that product's life cycle. Lilly's ceo

Eli Lilly joins the list of companies with CEO's earning hefty compensation this year. John Lechleiter's earning package for 2009 was reported at $20.9 million, three times higher than the $6.4 million he received in 2008.

By Arlene Weintraub and Meg Tirrell Feb. 25 (Bloomberg) — Shortly after he became chief executive officer of Eli Lilly & Co.

By Arlene Weintraub and Meg Tirrell Feb. See the original post here: Lilly CEO Tests Assembly-Line Drug Search to Offset $10 Billion Sales Loss.

By Arlene Weintraub and Meg Tirrell Feb. 25 (Bloomberg) -- Shortly after he became chief executive officer of Eli Lilly & Co. in April 2008, John Lechleiter , a former lab scientist, sent his senior executives a gift.

At first, it seems as if Eli Lilly (LLY) CEO John Lechleiter had to tighten his belt just like the rest of us last year. He didn't get part of h.

Eli Lilly CEO s Total Pay Rose To 20.9M In 2009 Proxy Shows Adjustments Helped Compensation of Lechleiter Jump by 44 The Indianapolis Star From Indianapolis Sta.

INDIANAPOLIS -- Eli Lilly and Co. CEO John Lechleiter received a compensation package valued at $16.4 million for 2009, up 54 percent from 2008, the year he became the drug maker's chief executive,

Such a plan could ultimately stifle innovation in the drug industry, he said in a speech before the US Chamber of Commerce.

The CEO says big deals are being driven by weakness and aren't a solution to long-term problems in the drug industry.